9.72
9.72 (0%)
As of Feb 14, 2025
Emergent Biosolutions Inc. [EBS]
Source:
Company Overview
Emergent Biosolutions Inc is a global life sciences company focused on providing innovative preparedness and response solutions addressing accidental, deliberate and naturally occurring Public Health Threats (“PHTs”). Our solutions include a product portfolio, a product development portfolio, and a contract development and manufacturing (“CDMO”) services portfolio.
| Country | United States |
| Headquarters | gaithersburg, maryland |
| Phone Number | 240-631-3200 |
| Industry | manufacturing |
| CEO | Emergent Biosolutions Inc. |
| Website | www.emergentbiosolutions.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $1,043.6 |
| Operating Profit | $-108.7 |
| Net Income | $-190.6 |
| Net Cash | $-6.1 |
Profit Ratios
| Gross Margin | $1,043.6 |
| Operating Margin | -10.4 |
| Profit as % of Revenues | -547.5% |
| Profit as % of Assets | -11.9% |
| Profit as % of Stockholder Equity | -39.5% |
Management Effectiveness
| Return on Equity | -39.5% |
| Return on Assets | -13.7% |
| Turnover Ratio | 65% |
| EBITA | $-43.6 |
Balance Sheet and Cash Flow Measures
| Total Assets | $1,389.7 |
| Total Liabilities | $906.9 |
| Operating Cash Flow | $58.7 |
| Investing Cash Flow | $125.2 |
| Financing Cash Flow | $-190 |
